Case study

Pricing and market access strategy for a haematology product in the GCC

Client Situation

Our client has a sickle disease portfolio and wanted to understand how to optimally launch in GCC markets through understanding price potential and feasibility of innovative contracting in order to boost patient access.

flag_image

Project Scope

    To understand price potential for a sickle cell disease product in GCC markets
flag_image

Solutions

  • In depth secondary research was conducted focusing on understanding the prevalence of sickle cell disease, patient journey and competitor products
  • Conducted primary research consisting of qualitative and quantitative discussions to understand the nuances within the sickle cell disease landscape across key geographies
  • Tested the price and access potential of the novel therapeutic agent
flag_image

Results

  • Successfully enabled our client to develop localised contracts and access strategy in each key market
  • Recommended optimal launch sequence to manage price referencing risks